Pro Medicus Limited
PME
Rang in aandelen
#1597
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aandeelprijs
$129.30
Marktkapitalisatie
$13.51B
Verandering (1 dag)
-0.17%
Verandering (1 jaar)
-30.83%
Land
AU
Handel Pro Medicus Limited (PME)
Categorie
Healthcare
Aantal uitstaande aandelen voor Pro Medicus Limited (PME)
Aantal uitstaande aandelen per June 2026: 104.47M
Volgens de laatste financiële rapporten en de aandelenkoers van Pro Medicus Limited bedraagt het huidige aantal uitstaande aandelen 104.47M. Aan het einde van June 2024 had het bedrijf 104.44M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Pro Medicus Limited (PME) van 2000 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 104.47M | -0.01% |
| 2025 | 104.48M | 0.03% |
| 2024 | 104.44M | 0.03% |
| 2023 | 104.41M | 0.09% |
| 2022 | 104.31M | 0.14% |
| 2021 | 104.17M | 0.26% |
| 2020 | 103.90M | 0.31% |
| 2019 | 103.57M | 0.37% |
| 2018 | 103.19M | 0.69% |
| 2017 | 102.49M | 1.09% |
| 2016 | 101.38M | 1.11% |
| 2015 | 100.26M | 0.00% |
| 2014 | 100.26M | 0.92% |
| 2013 | 99.35M | -0.91% |
| 2012 | 100.26M | -0.02% |
| 2011 | 100.28M | 0.00% |
| 2010 | 100.28M | 0.00% |
| 2009 | 100.28M | 0.00% |
| 2008 | 100.28M | 0.26% |
| 2007 | 100.02M | 0.02% |
| 2006 | 100.00M | 0.00% |
| 2005 | 100.00M | 0.00% |
| 2004 | 100.00M | 0.00% |
| 2003 | 100.00M | 0.00% |
| 2002 | 100.00M | 0.00% |
| 2001 | 100.00M | 0.00% |
| 2000 | 100.00M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| 453.00M | 333.62% |
US
|
|
| 205.38M | 96.59% |
US
|
|
| 179.92M | 72.22% |
US
|
|
| 129.98M | 24.42% |
US
|
|
| - | - |
US
|
